Sutro Biopharma, Inc.STRONASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank89
3Y CAGR+15.9%
5Y CAGR+19.9%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+15.9%/yr
vs +15.2%/yr prior
5Y CAGR
+19.9%/yr
Recent deceleration
Acceleration
+0.7pp
Accelerating
Percentile
P89
Within normal range
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$105.65M+70.3%
2024$62.04M-59.6%
2023$153.73M+126.8%
2022$67.77M+9.5%
2021$61.88M+44.8%
2020$42.72M-0.0%
2019$42.74M+11.2%
2018$38.42M-25.7%
2017$51.74M-13.4%
2016$59.73M-